Baseline immune variation predicts immune responses during vaccination, and the gene signatures capturing such immune variation seem to correlate with systemic lupus erythematosus (SLE) disease activity. Will the definition of these gene sets enable the development of the much needed concept of personalized medicine in SLE?
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
Purchase on Springer Link
Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Barrat, F. J., Crow, M. K. & Ivashkiv, L. B. Interferon target-gene expression and epigenomic signatures in health and disease. Nat. Immunol. 20, 1574–1583 (2019).
Nielsen, P. R. et al. Infections as risk factor for autoimmune diseases - a nationwide study. J. Autoimmun. 74, 176–181 (2016).
Kotliarov, Y. et al. Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus. Nat. Med. 26, 618–629 (2020).
Thorlacius, G. E., Wahren-Herlenius, M. & Rönnblom, L. An update on the role of type I interferons in systemic lupus erythematosus and Sjögren’s syndrome. Curr. Opin. Rheumatol. 30, 471–481 (2018).
Chiche, L. et al. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheumatol. 66, 1583–1595 (2014).
Tsang, J. S. et al. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell 157, 499–513 (2014).
Banchereau, R. et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell 165, 551–565 (2016).
Reid, S. et al. High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus. Ann. Rheum. Dis. 79, 363–369 (2020).
Brauner, S. et al. H1N1 vaccination in Sjögren’s syndrome triggers polyclonal B cell activation and promotes autoantibody production. Ann. Rheum. Dis. 76, 1755–1763 (2017).
Björk, A. et al. Viral antigens elicit augmented immune responses in primary Sjögren’s syndrome. Rheumatology https://doi.org/10.1093/rheumatology/kez509 (2019).
Acknowledgements
The authors thank the Swedish Research Council, the Heart-Lung Foundation, the Swedish Rheumatism Association, the King Gustaf the Vth 80-year Foundation and the Swedish Society of Medicine with the Ingegerd Johansson donation for provision of funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Rights and permissions
About this article
Cite this article
Wahren-Herlenius, M., Rönnblom, L. Learning from similarities between vaccine responses and SLE. Nat Rev Rheumatol 16, 355–356 (2020). https://doi.org/10.1038/s41584-020-0421-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-020-0421-5